Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD
Chi Ma(National Institutes of Health), Qiong Fu(National Institutes of Health), Laurence P. Diggs(National Institutes of Health), John C. McVey(National Institutes of Health), Justin McCallen(National Institutes of Health), Simon Wabitsch(National Institutes of Health), Benjamin Ruf(National Institutes of Health), Zachary J. Brown(National Institutes of Health), Bernd Heinrich(National Institutes of Health), Qianfei Zhang(National Institutes of Health), Umberto Rosato(National Institutes of Health), Sophie Wang(National Institutes of Health), Linda L. Cui(National Institutes of Health), Jay A. Berzofsky(National Institutes of Health), David E. Kleiner(National Institutes of Health), Dale B. Bosco(Mayo Clinic in Arizona), Long‐Jun Wu(Mayo Clinic in Arizona), Chunwei W. Lai(National Institutes of Health), Yaron Rotman(National Institutes of Health), Changqing Xie(National Institutes of Health), Firouzeh Korangy(National Institutes of Health), Tim F. Greten(National Institutes of Health)
Cited by 109Open Access
Abstract
Related Papers
NAFLD, NASH and liver cancer
Gregory Michelotti, Mariana Verdelho Machado, Anna Mae Diehl|Nature Reviews Gastroenterology & Hepatology|2013|963